Original Research
Published on 30 Jun 2022
Origanum syriacum L. Attenuates the Malignant Phenotype of MDA-MB231 Breast Cancer Cells
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.922196
- 7,166 views
- 17 citations
12 articles related to "Mda Mb231"
Articles
Original Research
Published on 14 Mar 2018
Apigenin and Luteolin Attenuate the Breaching of MDA-MB231 Breast Cancer Spheroids Through the Lymph Endothelial Barrier in Vitro
in Ethnopharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2018.00220
- 10,215 views
- 43 citations
Original Research
Published on 26 Jun 2017
Ror2 Signaling and Its Relevance in Breast Cancer Progression
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2017.00135
- 9,633 views
- 48 citations
Original Research
Published on 11 Jan 2021
Multi-Targeted Anticancer Activity of Imidazolate Phosphane Gold(I) Compounds by Inhibition of DHFR and TrxR in Breast Cancer Cells
in Medicinal and Pharmaceutical Chemistry
Frontiers in Chemistry
doi 10.3389/fchem.2020.602845
- 5,575 views
- 14 citations
Original Research
Published on 23 Jun 2023
Insights into the mechanisms governing P01 scorpion toxin effect against U87 glioblastoma cells oncogenesis
in Pharmacology of Ion Channels and Channelopathies
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1203247
- 3,516 views
- 7 citations
Original Research
Published on 31 May 2021
RUNX2 Phosphorylation by Tyrosine Kinase ABL Promotes Breast Cancer Invasion
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.665273
- 5,249 views
- 10 citations
Original Research
Published on 11 Nov 2021
Yerba Mate Modulates Tumor Cells Functions Involved in Metastasis in Breast Cancer Models
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2021.750197
- 6,586 views
- 7 citations
Original Research
Published on 17 Dec 2021
SIPL1, Regulated by MAZ, Promotes Tumor Progression and Predicts Poor Survival in Human Triple-Negative Breast Cancer
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2021.766790
- 4,489 views
- 13 citations
Original Research
Published on 19 Jun 2019
Fra-1 and c-Fos N-Terminal Deletion Mutants Impair Breast Tumor Cell Proliferation by Blocking Lipid Synthesis Activation
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2019.00544
- 3,838 views
- 16 citations
Original Research
Published on 15 May 2018
A Metabolomics Study of BPTES Altered Metabolism in Human Breast Cancer Cell Lines
in Metabolomics
Frontiers in Molecular Biosciences
doi 10.3389/fmolb.2018.00049
- 13,677 views
- 31 citations
Original Research
Published on 20 Dec 2024
Targeting CEA in metastatic triple negative breast cancer with image-guided radiation followed by Fab-mediated chimeric antigen receptor (CAR) T-cell therapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1499471
- 4,764 views
- 1 citation
![Anticancer Activity and Cisplatin Binding Ability of Bis-Quinoline and Bis-Isoquinoline Derived [Pd2L4]4+ Metallosupramolecular Cages](https://www.frontiersin.org/files/myhome article library/427892/427892_Thumb_400.jpg)
Original Research
Published on 22 Nov 2018
Anticancer Activity and Cisplatin Binding Ability of Bis-Quinoline and Bis-Isoquinoline Derived [Pd2L4]4+ Metallosupramolecular Cages
in Supramolecular Chemistry
Frontiers in Chemistry
doi 10.3389/fchem.2018.00563
- 6,396 views
- 42 citations